Clinical study overview*

Filter
Study Name Study Type Patients Status Primary Endpoint Link Type
SCAAR 69570 24-month FU available - Active (PDF)
BIOFLOW-I 30 Completed, 12-month FU available LLL at 9 months Active (PDF)
Madhavan et al. 20701 - TLF at mean 30 months Active (PDF)
Taglieri et al. 99039 - TLF at 12 months and the longest FU available Active (PDF)
REVELATION 120 Primary endpoint reached FFR at 9 months InActive
Hattrick-OCT 44 Primary endpoint reached Strut coverage at 3 months Active (PDF)
SMART-CHOICE 3000 Primary endpoint reached MACCE at 15 months InActive
TICO 3056 Completed, primary endpoint reached NACE at 12 months Active (PDF)
ISAR OCT 39 Primary endpoint reached Strut coverage at 6 months InActive
BIOSCIENCE 2119 Completed, 60-month FU available TLF at 12 months Active (PDF)
BIOLUX-RCT 210 18-month FU available LLL at 6 months InActive
BIOFLOW-V 1334 Completed, 60-months FU available TLF at 12 months Active Link
BIONYX 2488 36-month FU available TVF at 12 months Active (PDF)
ORIENT 372 36-month FU available LLL at 9 months InActive
BIO-RESORT 3514 Completed, 60-month FU available TVF at 12 months Active (PDF)
SORT OUT X 3146 12-month FU available TLF at 12 months Active (PDF)
BIOFLOW-DAPT 1948 12-month FU available Composite of Cardiac death, Myocardial Infarction and Definite or probable Stent thrombosis at 12 months Active (PDF)
BIOFLOW-VI 440 Completed, 60-month FU available LLL at 9 months Active (PDF)
PRISON-IV 330 Completed, 60-month FU available LLL at 9 months InActive
BIOSTEMI 1300 Completed, 60-months FU available TLF at 12 months Active (PDF)
SORT OUT IX 3151 24-month FU available TLF at 12 months Active (PDF)
HOST-IDEA 2013 12-month FU available TLF at 12 months Active (PDF)
BIOFLOW-II 452 Completed, 60-month FU available LLL at 9 months Active (PDF)
PREPARE-CALC 200 Completed Strategy success and LLL at 9 months InActive
BIODEGRADE 3850 36-month FU available TLF at 18 months InActive
BIOFLOW-IV 575 Completed, 60-month FU available TVF at 12 months InActive
BIOFLOW-III 1356 Completed, 60-month FU available TLF at 12 months Active (PDF)
HEROES 353 36-month FU available DOCE at 12 months Active (PDF)
ROSES 460 Preliminary results available TLF at 12 months InActive

*a selection of the full clinical program of the Orsiro family.

Clinical data conducted with Orsiro, Orsiro Mission’s predecessor device can be used to illustrate Orsiro Mission clinical outcomes.

© 2022 BIOTRONIK AG – All rights reserved.
Specifications are subject to modification, revision and improvement.

Are you interested in specific study data?

CONTACT US